Abbott Laboratories

Health Care Equipment

ABT

$ 120 0.18

Share price

$ 208 bn

Market Cap

$ 216 bn

Enterprise Value

Carbon footprint

GHG emissions per $ 1 mln investment

0.12x the weighted average for S&P 500

FY2020

Primary Climate Goal

This company has not set a company-wide target for an absolute reduction in GHG emissions yet

GHG emissions and Carbon intensity

Abbott Laboratories reported Total CO2e Emissions - Market-Based Scope 1 + Scope 2 for the twelve months ending 31 December 2020 at 906 Kt (-56 /-5.8% y-o-y). Also positively, carbon intensity decreased to 26 t (-4 /-13.2% y-o-y).

No public disclosure of Scope 3 emissions has been found for Abbott Laboratories at the moment.

The company has not set a company-wide target for an absolute reduction in GHG emissions yet.

Date	Total CO2e emissions (market-based Scope 1 & 2) (Kt)	Scope 1	Scope 2	Revenue (USDm)	Carbon intensity (tons of CO2e) / (USDm)
2020Q4	906	500	406	34,608	26
2019Q4	962	533	439	31,904	30
2018Q4	980	531	441	30,578	32
2017Q4	1,018	530	478	27,390	37
2016Q4	1,091	527	592	20,853	52
2015Q4	1,114	514	600	20,405	55

Abbott Laboratories

Carbon footprint

Primary Climate Goal

This company has not set a company-wide target for an absolute reduction in GHG emissions yet

GHG emissions and Carbon intensity

Abbott Laboratories's carbon footprint

Company environmental metrics